25
May
May
Lorundrostat, a new therapy that blocks the production of aldosterone from the adrenal glands, showed clinically significant and permanent reduction of blood pressure in 1083 patients with uncontrolled or resistant hypertension, in accordance with the results of the currently announced phase test 3. Data from the start test, announced at 34th The European meeting on […]